Your session is about to expire
← Back to Search
Telehealth Walking Exercise for Lower Limb Amputation (WEST Trial)
N/A
Recruiting
Led By Cory L. Christiansen, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Unilateral or bilateral lower-limb amputation (transmetatarsal to him disarticulation, traumatic or non-traumatic etiology)
Ability to walk two minutes without seated rest using prosthesis and assistive device if needed
Must not have
Active cancer treatment
Unstable heart condition including unstable angina, uncontrolled cardiac dysrhythmia, acute myocarditis, acute pericarditis, acute systemic infection
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion: baseline to 18 months
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to help Veterans with lower-limb amputation stay active through a walking exercise self-management program. The program provides remote support, personalized exercise plans, and peer encouragement. By promoting regular walking, the program seeks to improve health outcomes and reduce disability in this group.
Who is the study for?
This trial is for Veterans with lower-limb amputations who can walk for two minutes using a prosthesis and assistive device if needed, and manage daily living activities without help. It's not suitable for those with mild cognitive impairment, active cancer treatment, congenital or cancer-related amputation, acute infections, prisoners, or unstable heart conditions.
What is being tested?
The study tests an 18-month walking exercise self-management program delivered through telehealth to encourage sustained exercise in Veterans with lower-limb amputations. The goal is to reduce sedentary behavior by providing individualized training and peer support.
What are the potential side effects?
Since the intervention involves exercise management rather than medication or medical procedures, side effects are minimal but may include typical risks associated with starting a new exercise routine such as muscle soreness or strain.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had one or both of my legs amputated.
Select...
I can walk for two minutes without sitting down, using aids if necessary.
Select...
I can take care of my daily needs without help.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently receiving treatment for cancer.
Select...
I do not have any current severe heart problems or infections.
Select...
I have had an amputation due to birth defects or cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion: baseline to 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion: baseline to 18 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Average Daily Step Count
Secondary study objectives
2-Minute Step Test
30-Second Chair Rise Test
Comprehensive Lower Limb Amputee Socket Survey (CLASS)
+4 moreOther study objectives
Instrumented 2-Minute Step Test with Inertial Measurement Unit Data
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise self-managementExperimental Treatment1 Intervention
The EXP intervention will integrate conventional telehealth care with exercise self-management training and include structured 1:1 sessions (six) with an interventionist, peer group sessions (six), real-time step count feedback throughout the 18 months using a wrist-worn Fitbit with an LED interface, and tailored messaging with text messages designed using six key behavior-change techniques promoting exercise self-management.
Group II: Attention controlActive Control1 Intervention
The CTL intervention will incorporate the annual multidisciplinary team telehealth sessions, 12 attention-control telehealth sessions (six individual, six peer-group), and general health education text message prompts to match the timing and duration of the EXP group.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The Walking Exercise Self-Management Program for lower limb amputation patients focuses on behavior change through self-management training and peer support. This approach involves creating individualized exercise plans, remote monitoring, and providing peer support to encourage adherence and motivation.
These mechanisms are essential as they address both physical and psychological barriers to exercise, which are common in lower limb amputation patients. By promoting consistent physical activity, the program aims to improve functional capacity, reduce disability, and enhance overall quality of life.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,663 Previous Clinical Trials
3,427,210 Total Patients Enrolled
1 Trials studying Lower Limb Amputation
20 Patients Enrolled for Lower Limb Amputation
Cory L. Christiansen, PhDPrincipal InvestigatorRocky Mountain Regional VA Medical Center, Aurora, CO
3 Previous Clinical Trials
199 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently receiving treatment for cancer.I have had one or both of my legs amputated.I do not have any current severe heart problems or infections.I can walk for two minutes without sitting down, using aids if necessary.I have had an amputation due to birth defects or cancer.I can take care of my daily needs without help.
Research Study Groups:
This trial has the following groups:- Group 1: Exercise self-management
- Group 2: Attention control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger